Currently set to Index
Currently set to Follow

Start-ups are currently struggling to close financing rounds and investors are struggling to keep their portfolios afloat. In some cases, private investors are adopting a portfolio-first strategy and pausing investments into new targets to focus on existing portfolios.

To support highly innovative ventures during the crisis, the EIT Health Start-up Rescue Instrument aims to increase investor firepower and bridge the fundraising gap of start-ups in Series A, Series B and bridge-financing rounds.

Aescuvest-partner EIT Health – the EU-supported health innovation network – will leverage the value of an investor’s commitment and co-invest up to €500,000 in grants for options. For example, if a private investor invests at least €250,000, EIT Health will match this with a €500,000 grant and give the start-up a total cash injection of €750,000.

Through this instrument, EIT Health will enable start-ups to attract further investor commitment and propel their venture’s acceleration. In addition to providing a boost to bridge financing rounds, EIT Health will offer selected start-ups a strong network of partners and introduce them to other opportunities in the EIT Health portfolio programmes.

Applying is Simple

First, applicants should go to the EIT Health application platform and create an account.

Application Platform

They will need to select the Start-up Rescue Instrument and answer questions about their company, project, and team. You have to act quickly, deadline for applications is 01 June.

To get more information, simply join the information webinar which will take place on 26 May. For joining the session, registration is requested.

Get started today

Stay up to date on the latest investment opportunities and news at Aescuvest

By clicking on 'Sign up', you agree to receive the newsletter with information on, for example, our services, our company as well as to its analysis through individual measurement, storage and evaluation of opening rates and click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. Consent can be revoked with effect for the future. Detailed information is available in our data privacy terms.